Financial Management Professionals’s Takeda Pharmaceutical TAK Stock Holding History

Financial Management Professionals’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.23K	Sell	199 -12	-6%	-$199	﹤0.01%	735
2026 Q1	$3.91K	Buy	211 +86	+69%	+$1.51K	﹤0.01%	649
2025 Q4	$1.95K	Hold	125	–	–	﹤0.01%	731
2025 Q3	$1.83K	Hold	125	–	–	﹤0.01%	722
2025 Q2	$1.98K	Hold	125	–	–	﹤0.01%	752
2025 Q1	$1.86K	Sell	125 -450	-78%	-$6.3K	﹤0.01%	749
2024 Q4	$7.61K	Buy	575 +510	+785%	+$7.01K	﹤0.01%	549
2024 Q3	$1K	Hold	65	–	–	﹤0.01%	890
2024 Q2	$1K	Sell	65 -13	-17%	-$172	﹤0.01%	852
2024 Q1	$1K	Hold	78	–	–	﹤0.01%	905
2023 Q4	$1K	Hold	78	–	–	﹤0.01%	890
2023 Q3	$1K	Sell	78 -108	-58%	-$1.67K	﹤0.01%	836
2023 Q2	$3K	Sell	186 -20	-10%	-$328	﹤0.01%	720
2023 Q1	$3K	Sell	206 -244	-54%	-$3.89K	﹤0.01%	777
2022 Q4	$7K	Sell	450 -363	-45%	-$5.07K	﹤0.01%	575
2022 Q3	$11K	Buy	813 +721	+784%	+$10K	﹤0.01%	465
2022 Q2	$1K	Buy	+92	New	+$1.31K	﹤0.01%	884
2021 Q4	–	Sell	-797	Closed	-$13K	–	1084
2021 Q3	$13K	Buy	+797	New	+$13.4K	﹤0.01%	431

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Financial Management Professionals's TAK Position: Q2 2026 in Review

Financial Management Professionals reduced its Takeda Pharmaceutical (TAK) stake by 5.7% in Q2 2026, selling an estimated $199 and leaving 199 shares worth $3.23K. The position accounts for ﹤0.01% of the portfolio, ranked #735.

Financial Management Professionals first reported a position in TAK in Q3 2021 and has held it in 18 quarters since. The position peaked at $13K in Q3 2021. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Financial Management Professionals held 199 shares of Takeda Pharmaceutical worth $3.23K as of Q2 2026.
Financial Management Professionals sold 12 Takeda Pharmaceutical shares in Q2 2026, an estimated $199.
Takeda Pharmaceutical made up ﹤0.01% of Financial Management Professionals's portfolio in Q2 2026, its #735 holding.
Financial Management Professionals first reported a position in Takeda Pharmaceutical in Q3 2021 and has held it in 18 quarters since.
Financial Management Professionals's Takeda Pharmaceutical position peaked at $13K in Q3 2021.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Financial Management Professionals's 13F filing for Q2 2026, filed 9 Jul 2026.